Amit Agarwal MD, PhD

Dr. Amit Agarwal is a Team Head of Early Heme assets, Multiple myeloma, and Myeloid franchises at BeiGene. He received his medical degree from the Maharashtra Institute of Medical Education and a Doctor of Philosophy from Virginia Commonwealth University. He is board certified in Medical Oncology, Hematology, and Internal Medicine. His clinical and research interest is focused on hematological malignancies, especially plasma cell disorders including multiple myeloma. His subsequent research interest has focused on plasma cell disorders. He has been involved with clinical trials and translational research in MGUS, SMM, and MM. Dr. Agarwal has had the opportunity to work throughout the bench-to-bedside process and understand the important measures of translational study design.